Rockefeller Capital Management’s Bio-Rad Laboratories Class A BIO Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Shares Change % | Capital Flow | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2023
Q2 | – | Sell |
-534
| Closed | -$254K | – | 1829 |
|
|
2023
Q1 | $254K | Sell |
534
-125
| -19% | -$59.5K | ﹤0.01% | 1677 |
|
|
2022
Q4 | $276K | Sell |
659
-60
| -8% | -$25.1K | ﹤0.01% | 1513 |
|
|
2022
Q3 | $299K | Buy |
719
+124
| +21% | +$51.6K | ﹤0.01% | 1470 |
|
|
2022
Q2 | $294K | Buy |
595
+107
| +22% | +$52.9K | ﹤0.01% | 1475 |
|
|
2022
Q1 | $274K | Sell |
488
-1,119
| -70% | -$628K | ﹤0.01% | 1560 |
|
|
2021
Q4 | $1.21M | Sell |
1,607
-17
| -1% | -$12.8K | 0.01% | 983 |
|
|
2021
Q3 | $1.21M | Sell |
1,624
-106
| -6% | -$79K | 0.01% | 928 |
|
|
2021
Q2 | $1.11M | Sell |
1,730
-374
| -18% | -$241K | 0.01% | 889 |
|
|
2021
Q1 | $1.2M | Buy |
2,104
+16
| +0.8% | +$9.13K | 0.01% | 728 |
|
|
2020
Q4 | $1.22M | Buy |
2,088
+140
| +7% | +$81.6K | 0.01% | 641 |
|
|
2020
Q3 | $1M | Buy |
1,948
+285
| +17% | +$147K | 0.01% | 596 |
|
|
2020
Q2 | $751K | Buy |
1,663
+1,361
| +451% | +$615K | 0.01% | 600 |
|
|
2020
Q1 | $106K | Buy |
302
+91
| +43% | +$31.9K | ﹤0.01% | 998 |
|
|
2019
Q4 | $78K | Buy |
211
+5
| +2% | +$1.85K | ﹤0.01% | 1027 |
|
|
2019
Q3 | $69K | Buy |
206
+190
| +1,188% | +$63.6K | ﹤0.01% | 887 |
|
|
2019
Q2 | $5K | Sell |
16
-248
| -94% | -$77.5K | ﹤0.01% | 1416 |
|
|
2019
Q1 | $81K | Buy |
+264
| New | +$81K | ﹤0.01% | 804 |
|